Ming Tan
- Cancer Research top 0.2%
- Cancer, Hypoxia, and Metabolism 22
- MicroRNA in disease regulation 21
- Cancer-related molecular mechanisms research 18
- Oncology top 0.5%
- Cancer-related Molecular Pathways 15
- HER2/EGFR in Cancer Research 14
- Molecular Biology top 0.5%
- RNA modifications and cancer 13
- PI3K/AKT/mTOR signaling in cancer 10
- Health Informatics top 1%
- Immunology top 2%
-
- Autophagy in Disease and Therapy 12
- Co-authors
- Dihua YuJianrong LuEthan B. ButlerYinglan ZhaoMien‐Chie HungQingsong CaiØystein FodstadXiaoyan Zhou
- Partner nations
- United StatesChinaMalaysia
In The Last Decade
Ming Tan
229 papers receiving 13.6k citations
Hit Papers
Peers
Comparison fields: 5 of 184
- Cancer Research 4.3k
- Oncology 4.3k
- Molecular Biology 7.5k
- Health Informatics 138
- Immunology 1.5k
Countries citing papers authored by Ming Tan
This map shows the geographic impact of Ming Tan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ming Tan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ming Tan more than expected).
Fields of papers citing papers by Ming Tan
This network shows the impact of papers produced by Ming Tan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ming Tan. The network helps show where Ming Tan may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Ming Tan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2024 | 1 | |
| 3 | 2024 | 0 | |
| 4 | 2024 | 1 | |
| 5 | 2024 | 22 | |
| 6 | 2024 | 1 | |
| 7 | 2024 | 1 | |
| 8 | 2024 | 2 | |
| 9 | 2023 | 25 | |
| 10 | 2023 | 3 | |
| 11 | 2023 | 2 | |
| 12 | 2022 | 0 | |
| 13 | 2022 | 1 | |
| 14 | 2019 | 13 | |
| 15 | 2017 | 82 | |
| 16 | 2016 | 37 | |
| 17 | 2016 | 127 | |
| 18 | 2013 | 103 | |
| 19 | 2011 | 128 | |
| 20 | 2009 | 54 |
About Ming Tan
Ming Tan is a scholar working on Cancer Research, Pharmacology and Oncology, having authored 243 papers that have together received 13.9k indexed citations. Recurring topics across this work include Cancer, Hypoxia, and Metabolism (22 papers), MicroRNA in disease regulation (21 papers), Cancer-related molecular mechanisms research (18 papers), Cancer-related Molecular Pathways (15 papers), HER2/EGFR in Cancer Research (14 papers), RNA modifications and cancer (13 papers), Autophagy in Disease and Therapy (12 papers) and PI3K/AKT/mTOR signaling in cancer (10 papers). The work is most often cited by research in Cancer Research (4.3k citations), Oncology (4.3k citations) and Molecular Biology (7.5k citations). Ming Tan has collaborated with scholars based in United States, China and Malaysia. Frequent co-authors include Dihua Yu, Jianrong Lu, Ethan B. Butler, Yinglan Zhao, Mien‐Chie Hung, Qingsong Cai, Øystein Fodstad, Xiaoyan Zhou, Keng‐Hsueh Lan and Kristine S. Klos. Their work appears in journals such as Cancer Research, PLoS ONE, Journal of Ethnopharmacology, Cell Death and Disease and Oncotarget.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.